Severe asthma at COVID-19 time: what is new on biologic therapies.

Patrucco, Filippo; Villa, Elisa; Foci, Valentina; Benfante, Alida; Bellocchia, Michela; Solidoro, Paolo

Patrucco, Filippo; Villa, Elisa; Foci, Valentina; Benfante, Alida; Bellocchia, Michela; Solidoro, Paolo.

Patrucco F; Division of Respiratory Diseases, Department of Medicine, Maggiore della Carità University Hospital, Novara, Italy - filippo.patrucco@maggioreosp.novara.it.
Villa E; Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy - filippo.patrucco@maggioreosp.novara.it.
Foci V; Unit of Pneumology, A.S.L. Genova3, Villa Scassi Hospital, Genoa, Italy.
Benfante A; Unit U of Pneumology, Department of Medicine, A.S.L. Vercelli, Vercelli, Italy.
Bellocchia M; ProMISE Department, University of Palermo, Palermo, Italy.
Solidoro P; Unit U of Pneumology, Department of Cardiovascular and Thoracic Medicine, Città della Salute e della Scienza, University of Turin, Turin, Italy.

Minerva Med ; 112(1): 114-117, 2021 02.

Article in English | MEDLINE | ID: covidwho-1128278

Subject(s)

Asthma/complications; Asthma/therapy; Biological Therapy; COVID-19/complications; Humans; Severity of Illness Index

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Asthma / Biological Therapy / COVID-19 Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Minerva Med Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google